BioNTech SE

NASDAQ: BNTX · Real-Time Price · USD
113.54
0.84 (0.75%)
At close: Aug 15, 2025, 3:59 PM
113.81
0.24%
After-hours: Aug 15, 2025, 07:27 PM EDT

BioNTech SE Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.75B 3.82B 17.31B 18.98B
Cost of Revenue
541.3M 599.8M 4.53B 3.86B
Gross Profit
2.21B 3.22B 12.78B 15.12B
Operating Income
-1.31B 690.4M 12.64B 15.28B
Interest Income
437.6M 350.27M 48.5M 1.56M
Pretax Income
-677.7M 1.19B 12.95B 15.05B
Net Income
-665.3M 930.3M 9.43B 10.29B
Selling & General & Admin
599M 557.7M 544.2M 328.9M
Research & Development
2.25B 1.78B 1.46B 952.85M
Other Expenses
670.9M 188M -408.3M -128.8M
Operating Expenses
3.52B 2.53B 135.9M 200.1M
Interest Expense
12.6M 569.94K 18.9M 5.62M
Selling & Marketing Expenses
67.9M 62.7M 59.5M 50.4M
Cost & Expenses
4.07B 3.13B 4.67B 4.06B
Income Tax Expense
-12.4M 255.8M 3.52B 4.75B
Shares Outstanding (Basic)
240.4M 240.6M 243.3M 244M
Shares Outstanding (Diluted)
240.4M 242.7M 249.8M 259.7M
EPS (Basic)
-2.77 3.87 38.08 43.87
EPS (Diluted)
-2.77 3.83 37.09 41.21
EBITDA
-367.1M 1.09B 12.86B 15.73B
EBIT
-665.1M 1.19B 12.74B 15.65B
Depreciation & Amortization
298M 183.4M 121.08M 78.2M